Viewmind

ViewMind for private and public healthcare institutions

Precision care for
neurological diseases

ViewMind has the potential to significantly impact healthcare for brain diseases by addressing these unmet needs:

  • Challenging, costly, time-consuming neurological assessments.
  • High misdiagnosis rates: 18% for Alzheimer’s, 30% for Parkinson’s, and 20% for multiple sclerosis.
  • Lack of objective data to measure a patient’s response to treatment.

How healthcare institutions can use ViewMind
in their care settings

Brain health assessment

Quantify neurocognitive and brain alterations

  • Measure the health of 16 cognitive domains and 19 related brain regions in a 15-minute non-invasive test.
 
  • Specific test batteries can be used to find ocular patterns characteristic of various neurodegenerative diseases, disease progression, and even subclinical alterations.

Therapeutic impact measurement

Provide objective evidence on drug impact

  • Select the drug most likely to ameliorate symptoms based on the patient’s ocular digital phenotype.
 
  • Measure the state of different cognitive domains and related brain regions to track the impact of a therapeutic.

Neurocognitive performance monitoring

Track neurocognitive resources and brain changes

  • Quantify various aspects of neurocognitive performance and brain function.
 
  • Monitor small changes in neurocognitive performance over time, differentiating between disease-related and age-related alterations.

How healthcare professionals identify patients’ conditions with ViewMind

Traditional neurocognitive assessments can be
inconclusive and non-specific. ViewMind offers insights
into patients’ cognitive health.

Distinguishing between different neurocognitive diseases

A 45-year-old patient visited a neurologist showing attention problems, continuous headaches, and fatigue.

He had suffered from similar problems all his life, but nobody could diagnose his condition. The patient underwent ViewMind’s evaluations and our algorithms identified eye movement patterns consistent with dyslexia.

The patient was diagnosed and started treatment for dyslexia, which resulted in a tangible improvement in his quality of life.

“The neurocognitive assessment solutions offered by ViewMind reveal insight into a patient’s cognitive process and are extremely useful to aid in the assessment process to improve patient outcomes”.

 

Dr Gustavo Echevarria
Doctor

Providing a differential assessment based on eye movement patterns

A 65-year-old patient was showing an increasing level of cognitive impairment.

A number of traditional neurocognitive assessments were performed and the results were inconclusive. The possible causes were Parkinson’s disease, Alzheimer’s disease, or MCI caused by depression (requiring 3 very different treatments).

The patient underwent ViewMind’s evaluations, and our algorithms were able to identify that when the patient was presented with very specific visual exercises, the ocular movement patterns were not characteristic of Alzheimer’s or Parkinson’s.
“ViewMind’s precision neurocogntive digital biomarkers to assist a doctor make a differential diagnosis are unique and highly valuable in the clinical setting”.


Dr Gustavo Sgrilli
Doctor

ViewMind Technology

Non-invasive solution for hospitals,
neurology centers, memory clinics, and
elderly care centers

Group 10755

Patient
assessment

A clinical research coordinator or nurse practitioner can complete an online ViewMind training and certification in under 60 minutes.
Group 10756

Analysis of oculomotor patterns

After collecting data from more than a billion variable permutations, ViewMind’s proprietary context-aware AI algorithms analyze the data and identify ocular digital phenotype patterns associated with specific neurocognitive disorders.
Group 10757

Report

ViewMind generates a presumptive diagnostic report detailing information about the patient’s cognitive state based on the analysis. This report is made available to the physician.
Group 10658
download 2
Mark email read

To be updated on ViewMind news please click buttons

Group 10694
Group 10695

To contact ViewMind